Details of the Drug Reposition

General Information of This Drug (ID: DM2N5W6)

• Drug Name: LFX453 (DM2N5W6)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
External genital and perianal wart	DISMXE8S	1A95	Phase 2	[1]
Actinic keratosis	DISR1RC5	EK90.0	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)